“According to SNS Insider, The Global Medical Isotope Market was valued at USD 5.66 billion in 2023 and is projected to reach USD 12.15 billion by 2032, at a compound annual growth rate of 8.87% over the forecast period 2024-2032.”
An increase in the applications of medical isotopes for diagnostics and therapy, mainly in cancer treatment, fuels the market's growth. Medical isotopes such as technetium-99m, iodine-131, and lutetium-177 are very crucial for furthering nuclear medicine and targeted therapies.